| Aug 29 2024 |
Litigation Against Pharmacy Benefit Managers |
Young Law Group |
| Aug 29 2024 |
FDA to End MOU with AAFCO – Impact on Animal Food Ingredient Review |
Keller and Heckman LLP |
| Aug 29 2024 |
Why are TSCA Citizen Petitions Filed? — A Conversation with Michael Connett [Podcast] |
Bergeson & Campbell, P.C. |
| Aug 28 2024 |
This Week in 340B: August 20 – 26, 2024 |
McDermott Will & Emery |
| Aug 28 2024 |
APHIS Issues Regulatory Status Review Responses to University of Florida and Bioceres Crop Solutions |
Bergeson & Campbell, P.C. |
| Aug 28 2024 |
FDA Issues Warning Letter to Manufacturer of Lead-Contaminated Apple Cinnamon Products |
Keller and Heckman LLP |
| Aug 27 2024 |
Ready-to-Drink Cocktail Permits: Ready to Go in Pennsylvania |
Norris McLaughlin P.A. |
| Aug 27 2024 |
Judge Blocks New DOL H-2A Farmworker Visa Rule in 17 States |
Jackson Lewis P.C. |
| Aug 27 2024 |
PCRM NURA Program Will Hold Webinar Series on Human-Based Methods in FDA Submissions |
Bergeson & Campbell, P.C. |
| Aug 27 2024 |
China Proposed New Anti-Monopoly Guidelines for the Pharmaceutical Sector |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 27 2024 |
The Broad Impact of Edwards v. Meril on the Safe Harbor Provision |
Proskauer Rose LLP |
| Aug 27 2024 |
Biotech Company Settles with Three State AGs Over Security Practices |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 27 2024 |
Mondelēz Sued for Deceptive Cocoa Sustainability Labeling |
Keller and Heckman LLP |
| Aug 27 2024 |
Cannabis Businessman Learns the Perils of the Not-So “Fine Print” – A Sobering Lesson For Us All |
Bradley Arant Boult Cummings LLP |
| Aug 26 2024 |
2024 Pre-Election Analysis: Health Care Issues |
Mintz |
| Aug 26 2024 |
China Releases Draft Guidelines for Front-of-Pack Nutrition Labeling |
Keller and Heckman LLP |
| Aug 26 2024 |
The Bright Side of the Road: FDA Decision on MDMA Leaves Psychedelic Therapy Down, Far From Out |
Bradley Arant Boult Cummings LLP |
| Aug 23 2024 |
EPA Bans the Use of DCPA |
Norris McLaughlin P.A. |
| Aug 23 2024 |
HHS-OIG Highlights Fraud, Abuse Concerns With Manufacturer Offering Financial Assistance to Treat Infertility Side Effects |
Barnes & Thornburg LLP |
| Aug 22 2024 |
NASEM Will Hold Virtual Town Hall on September 5 as Part of Its Quadrennial Review of the NNI |
Bergeson & Campbell, P.C. |
| Aug 22 2024 |
Yes, You Can Patent Food Products! |
Foley & Lardner LLP |
| Aug 22 2024 |
First EU Application Submitted for Lab-Grown Meat Product as Novel Food |
Keller and Heckman LLP |
| Aug 22 2024 |
Federal Circuit Finds Prior Sale of Product Made By Secret Process Continues to Bar Patent on Process Post-AIA |
Barnes & Thornburg LLP |
| Aug 22 2024 |
FDA Posts Discussion Paper on Development of an Enhanced Systematic Process for Its Post-Market Assessment of Chemicals in Food; Comments Due December 6, 2024 |
Bergeson & Campbell, P.C. |
| Aug 22 2024 |
Patent by Secret Process: Perils of Pre-Patent Profiting |
McDermott Will & Emery |
| Aug 21 2024 |
CMS Finalizes Transitional Coverage for Emerging Technologies (TCET) Coverage Pathway |
Greenberg Traurig, LLP |
| Aug 21 2024 |
Second Circuit Affirms Win for Defendants in Challenge to Glucosamine Labeling on Federal Preemption Grounds |
Keller and Heckman LLP |
| Aug 21 2024 |
This Week in 340B: August 13 – 19, 2024 |
McDermott Will & Emery |
| Aug 21 2024 |
NSF Biomaterials Program Publishes RFI |
Bergeson & Campbell, P.C. |
| Aug 20 2024 |
Whistleblower Stops Medicaid Fraud at Crossroads |
Tycko & Zavareei LLP |
| Aug 20 2024 |
July 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Aug 20 2024 |
CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects |
Mintz |
| Aug 20 2024 |
FDA Issues Second Edition of Voluntary Sodium Reduction Goals |
Keller and Heckman LLP |
| Aug 20 2024 |
CMS Releases Final Procedural Notice on Transitional Coverage for Emerging Technology (TCET) |
McDermott Will & Emery |
| Aug 19 2024 |
CMS Issues Final Notice on Program for Breakthrough Device Reimbursement but Industry Looks to Congress for More Inclusive Solution |
Mintz |
